A detailed history of Asset Dedication, LLC transactions in Organon & Co. stock. As of the latest transaction made, Asset Dedication, LLC holds 361 shares of OGN stock, worth $6,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
361
Previous 458 21.18%
Holding current value
$6,523
Previous $9,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$18.65 - $23.03 $1,809 - $2,233
-97 Reduced 21.18%
361 $6,000
Q2 2024

Aug 06, 2024

SELL
$17.45 - $21.96 $506 - $636
-29 Reduced 5.95%
458 $9,000
Q1 2024

Apr 16, 2024

SELL
$13.78 - $18.8 $675 - $921
-49 Reduced 9.14%
487 $3,000
Q4 2023

Feb 08, 2024

SELL
$10.95 - $17.32 $1,270 - $2,009
-116 Reduced 17.79%
536 $2,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $1,177 - $1,687
-71 Reduced 9.82%
652 $3,000
Q2 2023

Aug 21, 2023

SELL
$19.27 - $24.63 $1,792 - $2,290
-93 Reduced 11.4%
723 $7,000
Q1 2023

Apr 21, 2023

SELL
$21.42 - $32.08 $642 - $962
-30 Reduced 3.55%
816 $10,000
Q4 2022

Jan 19, 2023

SELL
$23.31 - $28.61 $139 - $171
-6 Reduced 0.7%
846 $14,000
Q3 2022

Oct 27, 2022

SELL
$23.4 - $34.25 $2,644 - $3,870
-113 Reduced 11.71%
852 $10,000
Q2 2022

Jul 19, 2022

SELL
$31.66 - $38.9 $2,976 - $3,656
-94 Reduced 8.88%
965 $24,000
Q1 2022

Apr 21, 2022

SELL
$30.45 - $39.36 $19,061 - $24,639
-626 Reduced 37.15%
1,059 $27,000
Q4 2021

Jan 21, 2022

SELL
$28.67 - $37.13 $13,532 - $17,525
-472 Reduced 21.88%
1,685 $27,000
Q3 2021

Oct 18, 2021

SELL
$28.63 - $35.64 $5,210 - $6,486
-182 Reduced 7.78%
2,157 $36,000
Q2 2021

Jul 21, 2021

BUY
$28.45 - $38.0 $66,544 - $88,882
2,339 New
2,339 $39,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.6B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.